Not applicableEnrolling By InvitationNCT06885515What this trial is testingTelomeres Length in Israeli Fibrotic ILD PatientsWho this might be right forPulmonary Fibrosis Barzilai Medical Center 100
Post-approval studies (Phase 4)UnknownNCT03260556What this trial is testingPirfenidone for Progressive Fibrotic SarcoidosisWho this might be right forSarcoidosis, Pulmonary University of Cincinnati 60
Not applicableStudy completedNCT02044939What this trial is testingPulmonary Rehabilitation in Patients With SarcoidosisWho this might be right forStage 4 Pulmonary Sarcoidosis University Hospital, Lille 38
Testing effectiveness (Phase 2)Looking for participantsNCT06714123What this trial is testingSenicapoc in Patients With Worsening Fibrotic Interstitial Lung DiseaseWho this might be right forPulmonary Fibrosis, Interstitial Lung DiseaseIdiopathic Pulmonary Fibrosis Vejle Hospital 140
Testing effectiveness (Phase 2)UnknownNCT01450644What this trial is testingEvaluation of the Hospital2Home Palliative Care Service for Patients With Advanced Progressive Lung DiseaseWho this might be right forLung Disease Royal Marsden NHS Foundation Trust 52
Post-approval studies (Phase 4)Study completedNCT05799755What this trial is testingMyositis Interstitial Lung Disease Nintedanib TrialWho this might be right forMyositis Associated Interstitial Lund Disease (MA-ILD) Rohit Aggarwal, MD 49
Post-approval studies (Phase 4)Study completedNCT02286063What this trial is testingAmbulatory Oxygen in Fibrotic Lung Disease (FLD) (AmbOx)Who this might be right forLung; Disease, Fibroid (Chronic) Royal Brompton & Harefield NHS Foundation Trust 70
Not applicableStudy completedNCT05130034What this trial is testingHome-based Pulmonary Rehabilitation and Health Coaching in Fibrotic Interstitial Lung DiseaseWho this might be right forFibrotic Interstitial Lung Disease Mayo Clinic 81
Testing effectiveness (Phase 2)Ended earlyNCT01898377What this trial is testingImatinib Mesylate and Mycophenolate Mofetil for Steroid-Refractory Sclerotic/Fibrotic cGVHD in ChildrenWho this might be right forChronic Graft-versus-host Disease Seoul National University Hospital 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT05983471What this trial is testingEfficacy and Safety of ME-015 (Suplatast Tosilate) in Cough Related to Idiopathic Pulmonary Fibrosis (COSMIC-IPF)Who this might be right forIdiopathic Pulmonary FibrosisCoughIPF+3 more Melius Pharma AB 40
Testing effectiveness (Phase 2)Study completedNCT04308681What this trial is testingA Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung FibrosisWho this might be right forPulmonary Fibrosis Bristol-Myers Squibb 403
Testing effectiveness (Phase 2)Looking for participantsNCT06189820What this trial is testingRole of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung DiseasesWho this might be right forPulmonary FibrosisLung FibrosisIdiopathic Pulmonary Fibrosis+1 more Erasme University Hospital 70
Not applicableStudy completedNCT04316780What this trial is testingImpact of Pre-transplant Anti-fibrotic Therapy for IPF Upon Lung Transplant OutcomesWho this might be right forIdiopathic Pulmonary Fibrosis Steward St. Elizabeth's Medical Center of Boston, Inc. 320
Not applicableUnknownNCT06027333What this trial is testingSelf-efficacy and Well-being of Patients With Fibrotic Interstitial Lung DiseaseWho this might be right forInterstitial Lung DiseaseFibrotic Lung DiseaseSelf Efficacy+3 more Berner Reha Zentrum AG 80
Not applicableLooking for participantsNCT07332117What this trial is testingA Pilot Study to Assess Body Mass Composition Measurement Using BIA and Muscle Ultrasound in IPF and PPF Patients on Anti-fibrotic MedicationsWho this might be right forIdiopathic Pulmonary Fibrosis (IPF)Progressive Pulmonary Fibrosis Royal Brompton & Harefield NHS Foundation Trust 30
Not applicableStudy completedNCT03737409What this trial is testingPFOX: Pulmonary Fibrosis Ambulatory Oxygen TrialWho this might be right forFibrotic Interstitial Lung Disease Monash University 116
Testing effectiveness (Phase 2)Study completedNCT03221257What this trial is testingScleroderma Lung Study III - Combining Pirfenidone With MycophenolateWho this might be right forScleroderma, SystemicInterstitial Lung Disease Michael Roth 51
Not applicableActive Not RecruitingNCT04680832What this trial is testingExhaled Breath Analysis Using eNose Technology as a Biomarker for Diagnosis and Disease Progression in Fibrotic ILDWho this might be right forPulmonary Fibrosis Erasmus Medical Center 600
Not applicableLooking for participantsNCT07512687What this trial is testingTitrated Ambulatory Oxygen in Fibrotic ILD and COPD With Isolated Exertional HypoxemiaWho this might be right forInterstitial Lung DiseaseChronic Obstructive Pulmonary DiseaseHypoxemia State University of New York at Buffalo 24
Not applicableLooking for participantsNCT07457463What this trial is testingEvaluation of the Pulmonary Fibrosis Learning and Self-management Programme (FILIP)Who this might be right forLung Fibrosis Interstitial Insel Gruppe AG, University Hospital Bern 80